Anti-immunoglobulin E for the treatment of allergic disease

被引：7

作者：

Busse, William ^{[1
]}

Neaville, William ^{[1
]}

机构：

[1] Univ Wisconsin, Dept Med, Allergy & Clin Immunol Sect, Madison, WI 53792 USA

来源：

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY | 2001年 / 1卷 / 01期

关键词：

D O I：

10.1097/00130832-200102000-00017

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

IgE plays a central role in allergic disease and participates in the associated inflammatory process. A mainstay of treatment of allergic disease, including asthma, is allergen avoidance and treatment of symptoms. Presently, the most effective treatments for allergic diseases are directed towards a regulation of the inflammatory process with corticosteroids. An exciting new approach is anti-IgE (rhuMAb-E25), which would regulate the allergic process at the level of IgE. The following information will review recent experiences with anti-IgE and discuss the conditions in which this approach may be effective. (C) 2001 Lippincott Williams & Wilkins.

引用

页码：105 / 108

页数：4

共 8 条

[1] Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis [J].

Ädelroth, E ;

Rak, S ;

Haahtela, T ;

Aasand, G ;

Rosenhall, L ;

Zetterstrom, O ;

Byrne, A ;

Champain, K ;

Thirlwell, J ;

Della Cioppa, G ;

Sandström, T .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (02) :253-259

[2] Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response [J].

Boulet, LP ;

Chapman, KR ;

Cote, J ;

Kalra, S ;

Bhagat, R ;

Swystun, VA ;

Laviolette, M ;

Cleland, LD ;

Deschesnes, F ;

Su, JQ ;

DeVault, A ;

Fick, RB ;

Cockcroft, DW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) :1835-1840

[3] Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis [J].

Casale, TB ;

Bernstein, IL ;

Busse, WW ;

LaForce, CF ;

Tinkelman, DG ;

Stoltz, RR ;

Dockhorn, RJ ;

Reimann, J ;

Su, JQ ;

Fick, RB ;

Adelman, DC .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (01) :110-121

[4] The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects [J].

Fahy, JV ;

Fleming, HE ;

Wong, HH ;

Liu, JT ;

Su, JQ ;

Reimann, J ;

Fick, RB ;

Boushey, HA .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) :1828-1834

[5] Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects [J].

Fahy, JV ;

Cockcroft, DW ;

Boulet, LP ;

Wong, HH ;

Deschesnes, F ;

Davis, EE ;

Ruppel, J ;

Su, JQ ;

Adelman, DC .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :1023-1027

[6] Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma [J].

Haile, S ;

Lefort, J ;

Eum, SY ;

Dumarey, C ;

Huerre, M ;

Heusser, C ;

Vargaftig, BB .

EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (05) :961-969

[7]

Lötvall J, 1999, CURR PHARM DESIGN, V5, P757

[8] Treatment of allergic asthma with monoclonal anti-IgE antibody [J].

Milgrom, H ;

Fick, RB ;

Su, JQ ;

Reimann, JD ;

Bush, RK ;

Watrous, ML ;

Metzger, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1966-1973

← 1 →